Conference Code: 18AT01ICVVD
Conference Aims and Objectives
The ICVVD 2018: 20th International Conference on Viral Vaccine Development
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Viral Vaccine Development. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Viral Vaccine Development.
Call for Contributions
All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Viral Vaccine Development are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET
Federated conference series is an event that brings together significant number of recurring events; academic conferences, symposia, workshops, special sessions, and plenary talks in the field of science and technology since inception in 1999. Each event may run over any span of time within the conference days.
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the International Science Index (ISI)
, Google Scholar
, Semantic Scholar
, and other index databases. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Impact Factor Indicators
Special Journal Issues
has teamed up with the Special Journal Issue on Viral Vaccine Development
A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form
|Abstracts/Full-Text Paper Submission Deadline
||November 30, 2017
|Notification of Acceptance/Rejection
||December 5, 2017
|Final Paper (Camera Ready) Submission & Early Bird Registration Deadline
||December 16, 2017
||January 25 - 26, 2018
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers. Downloadable versions of the check list for
Please refer to the Paper Submission GUIDE
before submitting your paper.
Selected Conference Papers
1) Human Immunodeficiency Virus Infection and Cardiac Autonomic Neuropathy Sharan Badiger, Prema T. Akkasaligar, Deepak Kadeli 2) A Comparative Study of Virus Detection TechniquesSulaiman Al Amro, Ali Alkhalifah 3) Oncological Management of Medulloblastoma and New Viral Therapeutic TargetsA. Taqaddas 4) Rapid Detection System of Airborne PathogensShigenori Togashi, Kei Takenaka 5) Survey Based Data Security Evaluation in Pakistan Financial Institutions against Malicious AttacksNaveed Ghani, Samreen Javed 6) Molecular Epidemiology and Genotyping of Bovine Viral Diarrhea Virus in Xinjiang Uygur Autonomous Region of ChinaYan Ren, Jun Qiao, Xianxia Liu, Pengyan Wang, Qiang Fu, Huijun Shi, Fei Guo, Yuanzhi Wang, Hui Zhang, Jinliang Sheng, Xinli Gu, Xiao-Jun Liu, Chuangfu Chen 7) Impact of Hepatitis C Virus Chronic Infection on Quality of Life in EgyptAmmal M. Metwally, Ghada A. Abdel-Latif, Walaa A. Fouad, Thanaa M. Rabah, Amira Mohsen, Fatma A. Shaaban, Iman I. Salama 8) Identification of Binding Proteins That Interact with BVDV E2 Protein in Bovine Trophoblast CellYan Ren, Fei Guo, Jun Qiao, Shengwei Hu, Hui Zhang, Yuanzhi Wang, Pengyan Wang, Jinliang Sheng, Xinli Gu, Xiaojun Liu, Chuangfu Chen 9) Level of Behavioral Development for Hepatitis C Virus Cases versus Their Contacts: Does Infection Make a Difference and What Is Beyond?Ammal M. Metwally, Lobna A. El Etreby, Rehan M. Saleh, Ghada Abdrabou, Somia I. Salama, Amira Orabi, Mohamed Abdelrahman 10) Unnoticeable Mumps Infection in India: Does MMR Vaccine Protect against Circulating Mumps Virus Genotype C?Jeevan Malayan, Aparna Warrier, Padmasani Venkat Ramanan, Sanjeeva Reddy N, Elanchezhiyan Manickan 11) Features of the Immune Response in Mice were Immunized with Polio Vaccine in Combination with Chitosan Preparations as AdjuvantsNelly К. Akhmatova, Оlga V. Lebedinskaya, Stanislav G. Markushin, Elvin А. Akhmatov, Lidiya A.
Geiderova, Еlena А. Lebedinskaya, Vera M. Axenova, Аnatoliy P. Godovalov 12) Induction of Apoptosis by Newcastle Disease Virus Strains AF220 and V4-UPM in Human Promyelocytic Leukemia (HL60) and Human T-Lymphoblastic Leukemia (CEM-SS) CellsSiti Aishah Abu Bakar, Madihah Zawawi, Abdul Manaf Ali, Aini Ideris 13) Microalbuminuria in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency SyndromeSharan Badiger, Prema T. Akkasaligar, Patil LS, Manish Patel, Biradar MS 14) Herpes Simplex Virus Type I Infection of Mice Testis and Effect on FertilityVictor A. Naumenko, Yuriy A. Tyulenev, Alla A. Kushch 15) Dynamical Network Transmission of H1N1 Virus at the Local Level Transmission ModelP. Pongsumpun
Similar conferences about Medical and Health Sciences